Clinical and Dimensional Outcomes of Sealing Socket Abutment Combined to Alveolar Ridge Preservation
Launched by UNIVERSITY OF LIEGE · Sep 11, 2020
Trial Information
Current as of May 08, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to replace lost back teeth (molars and premolars) using a special type of implant called a sealing socket abutment (SSA) combined with a method to preserve the surrounding bone (alveolar ridge preservation, or ARP). The goal is to see how well this technique works in maintaining the shape of the gums and bone, as well as the success rate of the implants over time. Researchers will monitor patients for up to five years to check how healthy the area around the implant is and to measure any changes in the bone and gum tissue.
To participate in this study, individuals must be at least 18 years old, in generally good health, and have one tooth that cannot be saved (hopeless tooth) in the back of their mouth. Smokers, individuals with certain health conditions, or those currently pregnant are not eligible. Participants will receive an implant on the same day their tooth is removed, and follow-up visits will occur at 1, 3, and 5 years to evaluate the success of the procedure and overall oral health. This trial is currently active but not recruiting new participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • good general health (ASA I/II),
- • more than 18 years old,
- • non smoker,
- • one hopeless tooth,
- • healthy periodontal condition,
- • the presence of at least 2 mm of keratinized gingiva,
- • adequate plaque control (FMPS ≤ 25%), adequate bone quantity in the septum if present and at least 5 mm of bone in the apical region
- Exclusion Criteria:
- • auto-immune disease or immunocompromised patients,
- • uncontrolled diabetes,
- • use of steroids or biphosphonates,
- • local or systemic infection (medical treatment needed prior to entrance to the study), pregnancy or breastfeeding, alcoholism or chronically drug abuse.
- Local exclusion criteria:
- • bone availability requiring an angulated abutment,
- • untreated local inflammation,
- • cyst,
- • mucosal disease or oral lesions,
- • local irradiation therapy,
- • oral communication with sinus after the extraction.
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials